Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.
2.

Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm.

Antoniou S, Saxena M, Hamedi N, de Cates C, Moghul S, Lidder S, Kapil V, Lobo MD.

J Clin Hypertens (Greenwich). 2016 Feb;18(2):129-38. doi: 10.1111/jch.12637. Epub 2015 Aug 26.

3.

Understanding patient management: the need for medication adherence and persistence.

Chia Y.

Malays Fam Physician. 2008 Apr 30;3(1):2-6. eCollection 2008. Review.

4.

Antihypertensive drug class and adherence: an electronic monitoring study.

Moise N, Schwartz J, Bring R, Shimbo D, Kronish IM.

Am J Hypertens. 2015 Jun;28(6):717-21. doi: 10.1093/ajh/hpu199. Epub 2014 Oct 24.

5.

Adherence to antihypertensive medications: is prescribing the right pill enough?

Gosmanova EO, Kovesdy CP.

Nephrol Dial Transplant. 2015 Oct;30(10):1649-56. doi: 10.1093/ndt/gfu330. Epub 2014 Oct 21. Review.

6.

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.

Hasvold LP, Bodegård J, Thuresson M, Stålhammar J, Hammar N, Sundström J, Russell D, Kjeldsen SE.

J Hum Hypertens. 2014 Nov;28(11):663-9. doi: 10.1038/jhh.2014.43. Epub 2014 Jun 26.

7.

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting.

Degli Esposti L, Saragoni S, Buda S, Degli Esposti E.

Clinicoecon Outcomes Res. 2014 Apr 22;6:209-16. doi: 10.2147/CEOR.S55245. eCollection 2014.

8.

Frequency of cardiovascular events in patients treated with anti hypertensive agents: A cohort study based on claims data generated by primary care practice.

Russo P, Capone A, Sturani A, Degli Esposti E.

Curr Ther Res Clin Exp. 2004 Sep;65(5):398-412. doi: 10.1016/j.curtheres.2004.10.003.

9.

Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland.

Khan MU, Shah S, Hameed T.

J Pharm Bioallied Sci. 2014 Apr;6(2):104-8. doi: 10.4103/0975-7406.129175.

10.

Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis.

Lemstra M, Alsabbagh MW.

Patient Prefer Adherence. 2014 Feb 13;8:211-8. doi: 10.2147/PPA.S55382. eCollection 2014.

11.

The treatment of hypertension in people with dementia: a systematic review of observational studies.

Welsh TJ, Gladman JR, Gordon AL.

BMC Geriatr. 2014 Feb 12;14:19. doi: 10.1186/1471-2318-14-19. Review.

12.

Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.

Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA.

Hypertension. 2013 Oct;62(4):691-7. doi: 10.1161/HYPERTENSIONAHA.113.01448. Epub 2013 Aug 5.

13.
14.

Symptoms of depression and anxiety and adherence to antihypertensive medication.

Bautista LE, Vera-Cala LM, Colombo C, Smith P.

Am J Hypertens. 2012 Apr;25(4):505-11. doi: 10.1038/ajh.2011.256. Epub 2012 Jan 19.

15.

Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.

Powers BJ, Coeytaux RR, Dolor RJ, Hasselblad V, Patel UD, Yancy WS Jr, Gray RN, Irvine RJ, Kendrick AS, Sanders GD.

J Gen Intern Med. 2012 Jun;27(6):716-29. doi: 10.1007/s11606-011-1938-8. Epub 2011 Dec 7. Review.

16.

Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults.

Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, Frohlich ED, Re RN.

Hypertension. 2011 Nov;58(5):804-10. doi: 10.1161/HYPERTENSIONAHA.111.176859. Epub 2011 Oct 3.

17.

Physiologic tailoring of treatment in resistant hypertension.

Spence JD.

Curr Cardiol Rev. 2010 May;6(2):119-23. doi: 10.2174/157340310791162695.

18.

Meta-analysis: impact of drug class on adherence to antihypertensives.

Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM.

Circulation. 2011 Apr 19;123(15):1611-21. doi: 10.1161/CIRCULATIONAHA.110.983874. Epub 2011 Apr 4.

19.

Using primary care prescribing databases for pharmacovigilance.

Mohamed IN, Helms PJ, Simpson CR, Milne RM, McLay JS.

Br J Clin Pharmacol. 2011 Feb;71(2):244-9. doi: 10.1111/j.1365-2125.2010.03816.x.

20.

AVAPROMISE: A randomized clinical trial for increasing adherence through behavioural modification in essential hypertension.

Hamet P, Campbell N, Curnew G, Eastwood C, Pradhan A.

Exp Clin Cardiol. 2002 Winter;7(4):165-72.

Supplemental Content

Support Center